Related Experiment Video

Updated: Sep 25, 2026

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

Opportunities for improvement in the diagnosis and treatment of heart failure

Peter A McCullough1, Edward F Philbin, John A Spertus

  • 1Department of Basic Science, Cardiology Section, University of Missouri-Kansas City School of Medicine, Truman Medical Center, Kansas City, Missouri, USA. pmc975@yahoo.com

Clinical Cardiology
|May 29, 2003
PubMed

Insights

Early use of vasodilators and beta blockers in heart failure patients is linked to better survival. Optimizing initial diagnostic and treatment strategies can significantly improve outcomes for congestive heart failure (CHF) management.

Area of Science:

  • Cardiology
  • Pharmacotherapy
  • Health Services Research

Background:

  • Effective congestive heart failure (CHF) treatment is crucial for slowing disease progression and improving patient survival.
  • Understanding diagnostic and pharmacotherapy patterns in newly diagnosed heart failure is vital for optimizing patient outcomes.

Purpose of the Study:

  • To analyze diagnostic test utilization and pharmacotherapy patterns in patients with newly diagnosed heart failure.
  • To identify associations between initial treatment strategies and patient outcomes, including mortality.

Main Methods:

  • Analysis of claims data from 1995-1998 for 3,353 heart failure patients diagnosed within one year.
  • Evaluation of rates of diagnostic testing and prescribed drug categories as primary outcome measures.
  • Assessment of demographic variables and provider type in relation to care access.

Main Results:

  • Diagnostic testing rates varied significantly by gender, age, race, and provider type.
  • Only 4.7% of patients received all guideline-recommended diagnostics and treatments.
  • Patients evaluated for ischemic heart disease and treated with vasodilators or beta blockers showed the lowest crude mortality.

Conclusions:

  • Significant opportunities exist to enhance initial diagnostic and therapeutic care for heart failure patients.
  • Early administration of vasodilators and beta blockers appears to confer a survival benefit within the first year of treatment.
Abstract

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...